WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
PRODUCTIVE TECH (00650) Secures Orders for 29 New Equipment Units, Including Single-Wafer Cleaning Equipment and Furnace LPCVD Equipment
HANSOH PHARMA(03692): Almonertinib Marketing Authorization Application Resubmitted to the EU and Confirmed for Acceptance by the European Medicines Agency
Muyuan Foods Group (02714) September commercial pig sales revenue approximately RMB 8.52 billion, down 6.01% year-on-year.
PRODUCTIVE TECH (00650) Secures Orders for 29 New Equipment Units, Including Single-Wafer Cleaning Equipment and Furnace LPCVD Equipment
HANSOH PHARMA(03692): Almonertinib Marketing Authorization Application Resubmitted to the EU and Confirmed for Acceptance by the European Medicines Agency
Muyuan Foods Group (02714) September commercial pig sales revenue approximately RMB 8.52 billion, down 6.01% year-on-year.
